73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL

Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL

November 2023Thomas R. CollinsMolecules that link cancer driver genes and promoters of cell death genes produce potent killing of diffuse large B-cell lymphoma (DLBCL) cells, according to findings pub

Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL

November 2023Thomas R. CollinsMolecules that link cancer driver genes and promoters of cell death genes produce potent killing of diffuse large B-cell lymphoma (DLBCL) cells, according to findings pub
Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study

Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study

October 2023Katie RobinsonPatients undergoing a human leukocyte antigen (HLA)-matched allogeneic hematopoietic cell transplantation (alloHCT) with reduced-intensity conditioning who received a prophyl

Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study

October 2023Katie RobinsonPatients undergoing a human leukocyte antigen (HLA)-matched allogeneic hematopoietic cell transplantation (alloHCT) with reduced-intensity conditioning who received a prophyl
Polybrominated diphenyl ether linked to increased risk for cancer mortality

Polybrominated diphenyl ether linked to increased risk for cancer mortality

by Elana GotkinePolybrominated diphenyl ether (PBDE) exposure is associated with an increased risk for cancer mortality, according to a studypublishedinJAMA Network Open.Buyun Liu, M

Polybrominated diphenyl ether linked to increased risk for cancer mortality

by Elana GotkinePolybrominated diphenyl ether (PBDE) exposure is associated with an increased risk for cancer mortality, according to a studypublishedinJAMA Network Open.Buyun Liu, M
Five-year interval is safe for prostate cancer screening, research shows

Five-year interval is safe for prostate cancer screening, research shows

by European Association of UrologyCredit: CC0 Public DomainA simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.The PSA blood test

Five-year interval is safe for prostate cancer screening, research shows

by European Association of UrologyCredit: CC0 Public DomainA simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.The PSA blood test
Researchers use machine learning to unlock the genomic code in clinical cancer samples

Researchers use machine learning to unlock the genomic code in clinical cancer samples

by University of HelsinkiMutational signatures of formalin exposure. a C>T FFPE-only mutation count increases with formalin fixation time. We observed this increase in both unrepaired and repa

Researchers use machine learning to unlock the genomic code in clinical cancer samples

by University of HelsinkiMutational signatures of formalin exposure. a C>T FFPE-only mutation count increases with formalin fixation time. We observed this increase in both unrepaired and repa
New test predicts chance of living more than a year on targeted breast cancer treatment

New test predicts chance of living more than a year on targeted breast cancer treatment

by Institute of Cancer ResearchBreast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue). Credit: Julia Sero / the ICR, 2011A new test could pick out wom

New test predicts chance of living more than a year on targeted breast cancer treatment

by Institute of Cancer ResearchBreast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue). Credit: Julia Sero / the ICR, 2011A new test could pick out wom
The impact of cohesin mutations: Insights into a hidden regulator of alternative splicing in leukemia

The impact of cohesin mutations: Insights into a hidden regulator of alternative splicing in leukemia

by Justin Jackson , Medical XpressCohesin regulates alternative splicing. (A) Flowchart showing the experimental protocol, as detailed in Materials and Methods. (B) Schematic showing five different cl

The impact of cohesin mutations: Insights into a hidden regulator of alternative splicing in leukemia

by Justin Jackson , Medical XpressCohesin regulates alternative splicing. (A) Flowchart showing the experimental protocol, as detailed in Materials and Methods. (B) Schematic showing five different cl
Study analyses how far people will travel for specialist cancer care

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications
A novel network computer model to find co-occurring mutations—researchers improve search for cancer drivers

A novel network computer model to find co-occurring mutations—researchers improve search for cancer drivers

by Tina Hilding,Washington State UniversityNumber of mutations by variant type (A) before filtering and (B) after filtering. (C) Number of genes and their role in cancer. (D) Pie chart showing t

A novel network computer model to find co-occurring mutations—researchers improve search for cancer drivers

by Tina Hilding,Washington State UniversityNumber of mutations by variant type (A) before filtering and (B) after filtering. (C) Number of genes and their role in cancer. (D) Pie chart showing t
New lung cancer screening model removes barriers for central Texas' most vulnerable

New lung cancer screening model removes barriers for central Texas' most vulnerable

byUniversity of Texas at AustinCredit: Pixabay/CC0 Public DomainA new lung cancer screening initiative has made significant strides in overcoming barriers to care for low-income, uninsured and m

New lung cancer screening model removes barriers for central Texas' most vulnerable

byUniversity of Texas at AustinCredit: Pixabay/CC0 Public DomainA new lung cancer screening initiative has made significant strides in overcoming barriers to care for low-income, uninsured and m
Bioengineered antibodies target mutant HER2 proteins

Bioengineered antibodies target mutant HER2 proteins

byNYU Langone HealthCredit: Unsplash/CC0 Public DomainFor some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and

Bioengineered antibodies target mutant HER2 proteins

byNYU Langone HealthCredit: Unsplash/CC0 Public DomainFor some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and
Even with multiple breast tumors, mastectomy isn't always necessary: Study

Even with multiple breast tumors, mastectomy isn't always necessary: Study

by Denise MannSome women with multiple breast tumors can safely be spared breast removal surgery, choosing less invasive treatment instead, new research suggests.Under certain conditions,women&n

Even with multiple breast tumors, mastectomy isn't always necessary: Study

by Denise MannSome women with multiple breast tumors can safely be spared breast removal surgery, choosing less invasive treatment instead, new research suggests.Under certain conditions,women&n